Comparison of bleomycin-induced pulmonary apoptosis between NMRI mice and C57BL/6 mice

Research in Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 43-50

  Safaeian, L ^a   Jafarian, A ^a   Rabbani, M ^a   Sadeghi, H M ^a   Afshar Moghaddam, N ^b   Sarahroodi, S ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Bleomycin; C57Bl 6 mice; NMRI mice; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; IMMUNOREGULATION; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG FIBROSIS; LUNG WEIGHT; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; REGULATOR GENE;

EID: 84873372904     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol. 2002;27:141-50. (Pubitemid 34780793)
2. Kuwano K, Hagimoto N, Hara N. Molecular mechanisms of pulmonary fibrosis and current treatment. Curr Mol Med. 2001;1:551-573. (Pubitemid 33772035)
3. Uhal BD. The role of apoptosis in pulmonary fibrosis. Eur Respir Rev. 2008;17:138-144.
4. Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Am Thorac Soc. 2006;3:350-356. (Pubitemid 43845412)
5. Winkler MK, Fowlkes JL. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2002;283:L1-11.
6. Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Histol Histopathol. 2004;19:867-881. (Pubitemid 38855069)
7. Yan N, Shi Y. Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol. 2005;21:35-56. (Pubitemid 41740626)
8. Uhal BD. Apoptosis in lung fibrosis and repair. Chest 2002;122:293S-298S. (Pubitemid 36043016)
9. Kuwano K, Hagimoto N, Yoshimi M, Maeyama T, Nakanishi Y. Apoptosis signaling pathways as therapeutic targets in lung injury. Lett Drug Des Discov. 2004;1:263-268.
10. Razzaque MS, Ahsan N, Taguchi T. Role of apoptosis in fibrogenesis. Nephron. 2002;90: 365- 372. (Pubitemid 34310098)
11. Safaeian L, Jafarian A, Rabbani M, Sadeghi HM, Torabinia N, Alavi SA. The effect of AT1 receptor blockade on bax and bcl-2 expression inbleomycininduced pulmonary fibrosis. Daru. 2009;17:53-59.
12. Jafarian-Dehkordi A, Rabbani M, Sadeghi MH, Afshar-Moghaddam N, Alavi SA, Mahmoodi F, et al. Development and time-course of bleomycininduced pulmonary fibrosis in NMRI mice. Daru. 2007;15:1-6. (Pubitemid 46438952)
13. Safaeian L, Moghaddam NA, Jafarian A. Pneumonia associated with a single intratracheal dose of bleomycin in mice. Lab Anim. 2006;35:19-21. (Pubitemid 44330274)
14. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol. 2004;31:510-516. (Pubitemid 39463399)
15. Lemay AM, Haston CK. Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice. Physiol Genomics. 2005;23:54-61.
16. Safaeian L, Jafarian A, Rabbani M, Sadeghi HM, Torabiniaand N, Alavi SA. The role of strain variation in BAX and BCL-2 expression in murine bleomycin-induced pulmonary fibrosis. Pak J Biol Sci. 2008;11:2606-2612.
17. Failla M, Genovese T, Mazzon E, Fruciano M, Fagone E, Gili E, et al. 16, 16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis. Am J Respir Cell Mol Biol. 2009;41:50-58.
18. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467- 470. (Pubitemid 18098428)
19. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440-447.
20. Kuwano K, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol. 2000;190:221- 229. (Pubitemid 30082497)
21. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol. 2003;163:2523-2530. (Pubitemid 37466493)
22. Harrison JH Jr, Hoyt DG, Lazo JS. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and resistant strains of mice. Mol Pharmacol. 1989;36:231-238. (Pubitemid 19218790)
23. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res. 1992;18:29-43.
24. Haston CK, Tomko TG, Godin N, Kerckhoff L, Hallett MT. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet. 2005;42:464-473. (Pubitemid 40847233)
25. Salamone MF, Mavournin KH. Bone marrow micronucleus assay: a review of the mouse stocks used and their published mean spontaneous micronucleus frequencies. Environ Mol Mutagen. 1994;23:239-273. (Pubitemid 24227883)
26. Fattman CL, Gambelli F, Hoyle G, Pitt BR, Luis A. Epithelial expression of TIMP-1 does not alter sensitivity to bleomycin-induced lung injury in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L572-L581. (Pubitemid 351468857)
27. Tanino Y, Makita H, Miyamoto K, Betsuyaku T, Ohtsuka Y, Nishihira J, et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002;283:L156-L162. (Pubitemid 34764552)
28. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol. 1997;16:91-101. (Pubitemid 127497440)
29. Aoshiba K, Yasui S, Tamaoki J, Nagai A. The Fas/Fas-ligand system is not required for bleomycininduced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2000;162:695-700. (Pubitemid 30647221)
30. Moodley YP, Misso NLA, Scaffidi AK, Fogel- Petrovic M. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol. 2003;29:490-498. (Pubitemid 37222687)
31. Pottier N, Chupin C, Defamie V, Cardinaud B, Sutherland R, Rios G, et al. Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis. A Role for Dipeptidylpeptidase I and tissue inhibitor of metalloproteinase- 3? Am J Respir Crit Care Med. 2007;176:1098-1107. (Pubitemid 350223756)